Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) announced today that the German Patent Office has upheld the "Kreutzer-Limmer I" '235 (DE 10066235) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE